These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35561459)

  • 1. Generation of a human iPSC line CIBi010-A with a reporter for ASGR1 using CRISPR/Cas9.
    Fu J; Jiang L; Yu B; Liu Y; Wei R; Hu Y; Ho WI; Yang B; Chu M; Tse HF; Yang J
    Stem Cell Res; 2022 Jul; 62():102800. PubMed ID: 35561459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells.
    Peters DT; Henderson CA; Warren CR; Friesen M; Xia F; Becker CE; Musunuru K; Cowan CA
    Development; 2016 May; 143(9):1475-81. PubMed ID: 27143754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
    Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
    Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9.
    Xu Y; Wu Y; Guo D; Gao G; Lai K; Yang F; Wang K; Wu H; Lai L; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jul; 22():29-32. PubMed ID: 28952928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a PXR reporter human induced pluripotent stem cell line (PXR-mCherry hiPSC) using the CRISPR/Cas9 system.
    Kim H; Kim JW; Kim SJ; Choi YJ; Kim DS; Park HJ
    Stem Cell Res; 2018 Jan; 26():72-75. PubMed ID: 29247817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
    Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF
    JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a PDGFRB-mCherry knock-in reporter human induced pluripotent stem cell line (KITi001-A-1), using CRISPR/Cas9 nuclease.
    Jo S; Kim JW; Noh H; Kim H; Kim JH; Park HJ
    Stem Cell Res; 2023 Jun; 69():103081. PubMed ID: 37001365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Brachyury-mCherry knock-in reporter human pluripotent stem cell line (SNUe003-A-2) using CRISPR/CAS9 nuclease.
    Jung J; Hwang S; Seol H; Kim AH; Lee HM; Sung JJ; Jeong SM; Choi YM; Jun JK; Kim DW; Jang J
    Stem Cell Res; 2021 May; 53():102321. PubMed ID: 33878708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a
    Nouri P; Zimmer A; Brüggemann S; Friedrich R; Kühn R; Prakash N
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of TUBB3-mCherry knock-in human pluripotent stem cell line using CRISPR/Cas9 (SNUe003-A-4).
    Kim AH; Lee HM; Kim HS; Jung J; Seol H; Choi E; Lee S; Min Choi Y; Jun JK; Kim HS; Jang J
    Stem Cell Res; 2023 Jun; 69():103064. PubMed ID: 36913849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
    Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
    Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a NESTIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease.
    Lee Y; Choi HY; Kwon A; Park H; Park M; Kim YO; Kwak S; Koo SK
    Stem Cell Res; 2019 Oct; 40():101554. PubMed ID: 31499408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Celecoxib on Differentiation of Human Induced Pluripotent Stem Cells into Hepatocytes Involves STAT5 Activation.
    Okumura H; Nakanishi A; Hashita T; Iwao T; Matsunaga T
    Drug Metab Dispos; 2018 Nov; 46(11):1519-1527. PubMed ID: 30158250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing.
    Nur Patria Y; Lilianty J; Elefanty AG; Stanley EG; Labonne T; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 Jan; 42():101689. PubMed ID: 31884373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human GAPDH knock-in reporter iPSC lines for stable expression of tdTomato in pluripotent and differentiated culture conditions.
    Kamiya D; Yamashita T; Akaboshi T; Yamaguchi Y; Toyooka Y; Ikeya M
    Stem Cell Res; 2022 Apr; 60():102704. PubMed ID: 35176664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an EFNB2-2A-mCherry reporter human embryonic stem cell line using CRISPR/Cas9-mediated site-specific homologous recombination.
    Huang Y; Wu H; Han X; Wu J; Yu M; Zhao ZA; Shen Z; Hu S; Lei W
    Stem Cell Res; 2021 Apr; 52():102241. PubMed ID: 33611045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of Adult Features and Functions of Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells and Self-Organized as Organoids.
    Messina A; Luce E; Benzoubir N; Pasqua M; Pereira U; Humbert L; Eguether T; Rainteau D; Duclos-Vallée JC; Legallais C; Dubart-Kupperschmitt A
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing.
    Houweling PJ; Crossman V; Tiong CF; Coles CA; Taylor RL; Clayton JS; Graham A; Vlahos K; Howden SE; North KN
    Stem Cell Res; 2024 Mar; 75():103313. PubMed ID: 38277710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.